-
1
-
-
84925611946
-
Microenvironmental regulation of therapeutic response in cancer
-
Klemm F, Joyce JA. Microenvironmental regulation of therapeutic response in cancer. Trends Cell Biol 2015; 25: 198-213.
-
(2015)
Trends Cell Biol
, vol.25
, pp. 198-213
-
-
Klemm, F.1
Joyce, J.A.2
-
2
-
-
84922952448
-
Translational horizons in the tumor microenvironment: Harnessing breakthroughs and targeting cures
-
Sun Y. Translational horizons in the tumor microenvironment: harnessing breakthroughs and targeting cures. Med Res Rev 2015; 35: 408-436.
-
(2015)
Med Res Rev
, vol.35
, pp. 408-426
-
-
Sun, Y.1
-
3
-
-
84868640245
-
The tumor microenvironment controls drug sensitivity
-
Ostman A. The tumor microenvironment controls drug sensitivity. Nat Med 2012; 18: 1332-1334.
-
(2012)
Nat Med
, vol.18
, pp. 1332-1334
-
-
Ostman, A.1
-
4
-
-
84868633053
-
Treatment-induced damage to the tumor microenvironment promotes prostate cancer therapy resistance through WNT16B
-
Sun Y, Campisi J, Higano C, Beer TM, Porter P, Coleman I et al. Treatment-induced damage to the tumor microenvironment promotes prostate cancer therapy resistance through WNT16B. Nat Med 2012; 18: 1359-1368.
-
(2012)
Nat Med
, vol.18
, pp. 1359-1368
-
-
Sun, Y.1
Campisi, J.2
Higano, C.3
Beer, T.M.4
Porter, P.5
Coleman, I.6
-
5
-
-
68249096784
-
Persistent DNA damage signalling triggers senescence-associated inflammatory cytokine secretion
-
Rodier F, Coppe JP, Patil CK, Hoeijmakers WA, Munoz DP, Raza SR et al. Persistent DNA damage signalling triggers senescence-associated inflammatory cytokine secretion. Nat Cell Biol 2009; 11: 973-979.
-
(2009)
Nat Cell Biol
, vol.11
, pp. 973-979
-
-
Rodier, F.1
Coppe, J.P.2
Patil, C.K.3
Hoeijmakers, W.A.4
Munoz, D.P.5
Raza, S.R.6
-
6
-
-
84871846692
-
WNT signalling pathways as therapeutic targets in cancer
-
Anastas JN, Moon RT. WNT signalling pathways as therapeutic targets in cancer. Nat Rev Cancer 2013; 13: 11-26.
-
(2013)
Nat Rev Cancer
, vol.13
, pp. 11-26
-
-
Anastas, J.N.1
Moon, R.T.2
-
7
-
-
84923013040
-
DNA damage induces GDNF secretion in the tumor microenvironment with paracrine effects promoting prostate cancer treatment resistance
-
Huber RM, Lucas JM, Gomez-Sarosi LA, Coleman I, Zhao S, Coleman R et al. DNA damage induces GDNF secretion in the tumor microenvironment with paracrine effects promoting prostate cancer treatment resistance. Oncotarget 2014; 6: 2134-2147.
-
(2014)
Oncotarget
, vol.6
, pp. 2134-2147
-
-
Huber, R.M.1
Lucas, J.M.2
Gomez-Sarosi, L.A.3
Coleman, I.4
Zhao, S.5
Coleman, R.6
-
8
-
-
79958056651
-
The role of calcineurin/NFAT in SFRP2 induced angiogenesis--a rationale for breast cancer treatment with the calcineurin inhibitor tacrolimus
-
Siamakpour-Reihani S, Caster J, Bandhu Nepal D, Courtwright A, Hilliard E, Usary J et al. The role of calcineurin/NFAT in SFRP2 induced angiogenesis--a rationale for breast cancer treatment with the calcineurin inhibitor tacrolimus. PloS One 2011; 6: e20412.
-
(2011)
PloS One
, vol.6
, pp. e20412
-
-
Siamakpour-Reihani, S.1
Caster, J.2
Bandhu Nepal, D.3
Courtwright, A.4
Hilliard, E.5
Usary, J.6
-
9
-
-
84929938629
-
Tumor microenvironment in pathogenesis and drug resistance of non-Hodgkins lymphoma
-
Zhang S, Zhao W. Tumor microenvironment in pathogenesis and drug resistance of non-Hodgkins lymphoma. Zhonghua Xue Ye Xue Za Zhi 2014; 35: 466-469.
-
(2014)
Zhonghua Xue Ye Xue Za Zhi
, vol.35
, pp. 466-469
-
-
Zhang, S.1
Zhao, W.2
-
10
-
-
84900332712
-
Tumor microenvironment and therapeutic resistance process
-
Borriello L, DeClerck YA. Tumor microenvironment and therapeutic resistance process. Med Sci 2014; 30: 445-451.
-
(2014)
Med Sci
, vol.30
, pp. 445-451
-
-
Borriello, L.1
DeClerck, Y.A.2
-
11
-
-
84891757812
-
CD44 expressed on cancer-associated fibroblasts is a functional molecule supporting the stemness and drug resistance of malignant cancer cells in the tumor microenvironment
-
Kinugasa Y, Matsui T, Takakura N. CD44 expressed on cancer-associated fibroblasts is a functional molecule supporting the stemness and drug resistance of malignant cancer cells in the tumor microenvironment. Stem Cells 2014; 32: 145-156.
-
(2014)
Stem Cells
, vol.32
, pp. 145-156
-
-
Kinugasa, Y.1
Matsui, T.2
Takakura, N.3
-
12
-
-
85028107326
-
Drug resistance in metastatic castration-resistant prostate cancer
-
Seruga B, Ocana A, Tannock IF. Drug resistance in metastatic castration-resistant prostate cancer. Nat Rev Clin Oncol 2011; 8: 12-23.
-
(2011)
Nat Rev Clin Oncol
, vol.8
, pp. 12-23
-
-
Seruga, B.1
Ocana, A.2
Tannock, I.F.3
-
13
-
-
84908450488
-
Systemic therapy in men with metastatic castration-resistant prostate cancer: American Society of Clinical Oncology and Cancer Care Ontario Clinical Practice Guideline
-
Basch E, Loblaw DA, Oliver TK, Carducci M, Chen RC, Frame JN et al. systemic therapy in men with metastatic castration-resistant prostate cancer: American Society of Clinical Oncology and Cancer Care Ontario Clinical Practice Guideline. J Clin Oncol 2014; 32: U3436-U3133.
-
(2014)
J Clin Oncol
, vol.32
, pp. U3133-U3436
-
-
Basch, E.1
Loblaw, D.A.2
Oliver, T.K.3
Carducci, M.4
Chen, R.C.5
Frame, J.N.6
-
14
-
-
84890531162
-
Prognostic model predicting metastatic castration-resistant prostate cancer survival in men treated with second-line chemotherapy
-
Halabi S, Lin CY, Small EJ, Armstrong AJ, Kaplan EB, Petrylak D et al. Prognostic model predicting metastatic castration-resistant prostate cancer survival in men treated with second-line chemotherapy. J Natl Cancer Inst 2013; 105: 1729-1737.
-
(2013)
J Natl Cancer Inst
, vol.105
, pp. 1729-1737
-
-
Halabi, S.1
Lin, C.Y.2
Small, E.J.3
Armstrong, A.J.4
Kaplan, E.B.5
Petrylak, D.6
-
15
-
-
66349089836
-
Secreted frizzle-related protein 2 stimulates angiogenesis via a calcineurin/NFAT signaling pathway
-
Courtwright A, Siamakpour-Reihani S, Arbiser JL, Banet N, Hilliard E, Fried L et al. Secreted frizzle-related protein 2 stimulates angiogenesis via a calcineurin/NFAT signaling pathway. Cancer Res 2009; 69: 4621-4628.
-
(2009)
Cancer Res
, vol.69
, pp. 4621-4628
-
-
Courtwright, A.1
Siamakpour-Reihani, S.2
Arbiser, J.L.3
Banet, N.4
Hilliard, E.5
Fried, L.6
-
16
-
-
84864483190
-
Molecular pathways: Involving microenvironment damage responses in cancer therapy resistance
-
Sun Y, Nelson PS. Molecular pathways: involving microenvironment damage responses in cancer therapy resistance. Clin Cancer Res 2012; 18: 4019-4025.
-
(2012)
Clin Cancer Res
, vol.18
, pp. 4019-4025
-
-
Sun, Y.1
Nelson, P.S.2
-
17
-
-
84891713034
-
Senescenceassociated secretory phenotypes reveal cell-nonautonomous functions of oncogenic RAS and the p53 tumor suppressor
-
Coppe JP, Patil CK, Rodier F, Sun Y, Munoz DP, Goldstein J et al. Senescenceassociated secretory phenotypes reveal cell-nonautonomous functions of oncogenic RAS and the p53 tumor suppressor. PLoS Biol 2008; 6: 2853-2868.
-
(2008)
PLoS Biol
, vol.6
, pp. 2853-2868
-
-
Coppe, J.P.1
Patil, C.K.2
Rodier, F.3
Sun, Y.4
Munoz, D.P.5
Goldstein, J.6
-
18
-
-
84864010194
-
Glucocorticoids suppress selected components of the senescence-associated secretory phenotype
-
Laberge RM, Zhou L, Sarantos MR, Rodier F, Freund A, de Keizer PL et al. Glucocorticoids suppress selected components of the senescence-associated secretory phenotype. Aging Cell 2012; 11: 569-578.
-
(2012)
Aging Cell
, vol.11
, pp. 569-578
-
-
Laberge, R.M.1
Zhou, L.2
Sarantos, M.R.3
Rodier, F.4
Freund, A.5
De Keizer, P.L.6
-
19
-
-
77952671657
-
The SFRP family of WNT inhibitors function as novel tumor suppressor genes epigenetically silenced in medulloblastoma
-
Kongkham PN, Northcott PA, Croul SE, Smith CA, Taylor MD, Rutka JT. The SFRP family of WNT inhibitors function as novel tumor suppressor genes epigenetically silenced in medulloblastoma. Oncogene 2010; 29: 3017-3024.
-
(2010)
Oncogene
, vol.29
, pp. 3017-3024
-
-
Kongkham, P.N.1
Northcott, P.A.2
Croul, S.E.3
Smith, C.A.4
Taylor, M.D.5
Rutka, J.T.6
-
20
-
-
83555173400
-
The complex roles of Wnt antagonists in RCC
-
Saini S, Majid S, Dahiya R. The complex roles of Wnt antagonists in RCC. Nat Rev Urol 2011; 8: 690-699.
-
(2011)
Nat Rev Urol
, vol.8
, pp. 690-699
-
-
Saini, S.1
Majid, S.2
Dahiya, R.3
-
21
-
-
0034738968
-
Secreted Frizzled-related proteins inhibit motility and promote growth of human malignant glioma cells
-
Roth W, Wild-Bode C, Platten M, Grimmel C, Melkonyan HS, Dichgans J et al. Secreted Frizzled-related proteins inhibit motility and promote growth of human malignant glioma cells. Oncogene 2000; 19: 4210-4220.
-
(2000)
Oncogene
, vol.19
, pp. 4210-4220
-
-
Roth, W.1
Wild-Bode, C.2
Platten, M.3
Grimmel, C.4
Melkonyan, H.S.5
Dichgans, J.6
-
22
-
-
0024708518
-
The distribution of secondary growths in cancer of the breast
-
Paget S. The distribution of secondary growths in cancer of the breast. 1889. Cancer Metastasis Rev 1989; 8: 98-101.
-
(1889)
Cancer Metastasis Rev
, vol.1989
, Issue.8
, pp. 98-101
-
-
Paget, S.1
-
23
-
-
84872867267
-
LRP-6 is a coreceptor for multiple fibrogenic signaling pathways in pericytes and myofibroblasts that are inhibited by DKK-1
-
Ren SY, Johnson BG, Kida Y, Ip C, Davidson KC, Lin SL et al. LRP-6 is a coreceptor for multiple fibrogenic signaling pathways in pericytes and myofibroblasts that are inhibited by DKK-1. Proc Natl Acad Sci USA 2013; 110: 1440-1445.
-
(2013)
Proc Natl Acad Sci USA
, vol.110
, pp. 1440-1445
-
-
Ren, S.Y.1
Johnson, B.G.2
Kida, Y.3
Ip, C.4
Davidson, K.C.5
Lin, S.L.6
-
24
-
-
80555131057
-
Crystal structures of the extracellular domain of LRP6 and its complex with DKK1
-
1204-U1244.
-
Cheng ZH, Biechele T, Wei ZY, Morrone S, Moon RT, Wang LG et al. Crystal structures of the extracellular domain of LRP6 and its complex with DKK1. Nat Struct Mol Biol 2011; 18: 1204-U1244.
-
(2011)
Nat Struct Mol Biol
, vol.18
-
-
Zh, C.1
Biechele, T.2
Wei, Z.Y.3
Morrone, S.4
Moon, R.T.5
Wang, L.G.6
-
25
-
-
84861165397
-
The Structural Basis of DKK-Mediated Inhibition of Wnt/LRP Signaling
-
Bao J, Zheng JJ, Wu DQ. The Structural Basis of DKK-Mediated Inhibition of Wnt/LRP Signaling. Sci Signal 2012; 5: pe22.
-
(2012)
Sci Signal
, vol.5
, pp. e22
-
-
Bao, J.1
Zheng, J.J.2
Wu, D.Q.3
-
26
-
-
84902334205
-
Therapeutic targeting of BET bromodomain proteins in castration-resistant prostate cancer
-
Asangani IA, Dommeti VL, Wang XJ, Malik R, Cieslik M, Yang RD et al. Therapeutic targeting of BET bromodomain proteins in castration-resistant prostate cancer. Nature 2014; 510: 278-282.
-
(2014)
Nature
, vol.510
, pp. 278-282
-
-
Asangani, I.A.1
Dommeti, V.L.2
Wang, X.J.3
Malik, R.4
Cieslik, M.5
Yang, R.D.6
-
27
-
-
84920125252
-
Tackling the tumor microenvironment: What challenge does it pose to anticancer therapies?
-
Chen F, Qi X, Qian M, Dai Y, Sun Y. Tackling the tumor microenvironment: what challenge does it pose to anticancer therapies? Protein Cell 2014; 5: 816-826.
-
(2014)
Protein Cell
, vol.5
, pp. 816-826
-
-
Chen, F.1
Qi, X.2
Qian, M.3
Dai, Y.4
Sun, Y.5
-
28
-
-
84864285794
-
Tumour micro-environment elicits innate resistance to RAF inhibitors through HGF secretion
-
Straussman R, Morikawa T, Shee K, Barzily-Rokni M, Qian ZR, Du JY et al. Tumour micro-environment elicits innate resistance to RAF inhibitors through HGF secretion. Nature 2012; 487: 500-504.
-
(2012)
Nature
, vol.487
, pp. 500-504
-
-
Straussman, R.1
Morikawa, T.2
Shee, K.3
Barzily-Rokni, M.4
Qian, Z.R.5
Du, J.Y.6
-
29
-
-
84864286442
-
Widespread potential for growth-factor-driven resistance to anticancer kinase inhibitors
-
Wilson TR, Fridlyand J, Yan YB, Penuel E, Burton L, Chan E et al. Widespread potential for growth-factor-driven resistance to anticancer kinase inhibitors. Nature 2012; 487: 505-509.
-
(2012)
Nature
, vol.487
, pp. 505-509
-
-
Wilson, T.R.1
Fridlyand, J.2
Yan, Y.B.3
Penuel, E.4
Burton, L.5
Chan, E.6
-
31
-
-
84961289380
-
Bruton tyrosine kinase is a therapeutic target in stem-like cells from multiple myeloma
-
Yang Y, Shi J, Gu Z, Salama ME, Das S, Wendlandt E et al. Bruton tyrosine kinase is a therapeutic target in stem-like cells from multiple myeloma. Cancer Res 2015; 75: 594-604.
-
(2015)
Cancer Res
, vol.75
, pp. 594-604
-
-
Yang, Y.1
Shi, J.2
Gu, Z.3
Salama, M.E.4
Das, S.5
Wendlandt, E.6
-
32
-
-
84884921969
-
Targeting cancer stem cells to suppress acquired chemotherapy resistance
-
Vidal SJ, Rodriguez-Bravo V, Galsky M, Cordon-Cardo C, Domingo-Domenech J. Targeting cancer stem cells to suppress acquired chemotherapy resistance. Oncogene 2014; 33: 4451-4463.
-
(2014)
Oncogene
, vol.33
, pp. 4451-4463
-
-
Vidal, S.J.1
Rodriguez-Bravo, V.2
Galsky, M.3
Cordon-Cardo, C.4
Domingo-Domenech, J.5
-
33
-
-
84885234293
-
Cell-autonomous and non-cell-autonomous mechanisms of HGF/MET-driven resistance to targeted therapies: From basic research to a clinical perspective
-
Corso S, Giordano S. Cell-autonomous and non-cell-autonomous mechanisms of HGF/MET-driven resistance to targeted therapies: from basic research to a clinical perspective. Cancer Discov 2013; 3: 978-992.
-
(2013)
Cancer Discov
, vol.3
, pp. 978-992
-
-
Corso, S.1
Giordano, S.2
-
34
-
-
84928749945
-
New horizons in tumor microenvironment biology: Challenges and opportunities
-
Chen F, Zhuang X, Lin L, Yu P, Wang Y, Shi Y et al. New horizons in tumor microenvironment biology: challenges and opportunities. BMC Med 2015; 13: 278.
-
(2015)
BMC Med
, vol.13
, pp. 278
-
-
Chen, F.1
Zhuang, X.2
Lin, L.3
Yu, P.4
Wang, Y.5
Shi, Y.6
-
35
-
-
73649118223
-
WNT16B is a new marker of cellular senescence that regulates p53 activity and the phosphoinositide 3-kinase/AKT pathway
-
Binet R. WNT16B is a new marker of cellular senescence that regulates p53 activity and the phosphoinositide 3-kinase/AKT pathway. Cancer Res 2009; 69: 9183-9191.
-
(2009)
Cancer Res
, vol.69
, pp. 9183-9191
-
-
Binet, R.1
-
36
-
-
77956938052
-
Secreted Frizzled-related protein-2 (sFRP2) augments canonical Wnt3a-induced signaling
-
von Marschall Z, Fisher LW. Secreted Frizzled-related protein-2 (sFRP2) augments canonical Wnt3a-induced signaling. Biochem Biophys Res Commun 2010; 400: 299-304.
-
(2010)
Biochem Biophys Res Commun
, vol.400
, pp. 299-304
-
-
Von Marschall, Z.1
Fisher, L.W.2
-
37
-
-
71449089518
-
Secreted Frizzled-related proteins enhance the diffusion of Wnt ligands and expand their signalling range
-
Mii Y, Taira M. Secreted Frizzled-related proteins enhance the diffusion of Wnt ligands and expand their signalling range. Development 2009; 136: 4083-4088.
-
(2009)
Development
, vol.136
, pp. 4083-4088
-
-
Mii, Y.1
Taira, M.2
-
38
-
-
84861165397
-
The structural basis of DKK-mediated inhibition of Wnt/LRP signaling
-
Bao J, Zheng JJ, Wu D. The structural basis of DKK-mediated inhibition of Wnt/LRP signaling. Sci Signal 2012; 5: pe22.
-
(2012)
Sci Signal
, vol.5
, pp. e22
-
-
Bao, J.1
Zheng, J.J.2
Wu, D.3
-
39
-
-
84860503063
-
Chromatin remodeling underlies the senescence-associated secretory phenotype of tumor stromal fibroblasts that supports cancer progression
-
Pazolli E, Alspach E, Milczarek A, Prior J, Piwnica-Worms D, Stewart SA. Chromatin remodeling underlies the senescence-associated secretory phenotype of tumor stromal fibroblasts that supports cancer progression. Cancer Res 2012; 72: 2251-2261.
-
(2012)
Cancer Res
, vol.72
, pp. 2251-2261
-
-
Pazolli, E.1
Alspach, E.2
Milczarek, A.3
Prior, J.4
Piwnica-Worms, D.5
Stewart, S.A.6
-
40
-
-
80054789761
-
Control of the senescence-associated secretory phenotype by NF-kappaB promotes senescence and enhances chemosensitivity
-
Chien Y, Scuoppo C, Wang X, Fang X, Balgley B, Bolden JE et al. Control of the senescence-associated secretory phenotype by NF-kappaB promotes senescence and enhances chemosensitivity. Genes Dev 2011; 25: 2125-2136.
-
(2011)
Genes Dev
, vol.25
, pp. 2125-2136
-
-
Chien, Y.1
Scuoppo, C.2
Wang, X.3
Fang, X.4
Balgley, B.5
Bolden, J.E.6
-
41
-
-
70350125106
-
Cell surface-bound IL- -1alpha is an upstream regulator of the senescence-associated IL-6/IL-8 cytokine network
-
Orjalo AV, Bhaumik D, Gengler BK, Scott GK, Campisi J. Cell surface-bound IL- -1alpha is an upstream regulator of the senescence-associated IL-6/IL-8 cytokine network. Proc Natl Acad Sci USA 2009; 106: 17031-17036.
-
(2009)
Proc Natl Acad Sci USA
, vol.106
, pp. 17031-17036
-
-
Orjalo, A.V.1
Bhaumik, D.2
Gengler, B.K.3
Scott, G.K.4
Campisi, J.5
-
42
-
-
84904043515
-
P38MAPK plays a crucial role in stromal-mediated tumorigenesis
-
Alspach E, Flanagan KC, Luo X, Ruhland MK, Huang H, Pazolli E et al. p38MAPK plays a crucial role in stromal-mediated tumorigenesis. Cancer Discov 2014; 4: 716-729.
-
(2014)
Cancer Discov
, vol.4
, pp. 716-729
-
-
Alspach, E.1
Flanagan, K.C.2
Luo, X.3
Ruhland, M.K.4
Huang, H.5
Pazolli, E.6
-
43
-
-
77950906172
-
GADD45beta enhances Col10a1 transcription via the MTK1/MKK3/6/p38 axis and activation of C/EBPbeta-TAD4 in terminally differentiating chondrocytes
-
Tsuchimochi K, Otero M, Dragomir CL, Plumb DA, Zerbini LF, Libermann TA et al. GADD45beta enhances Col10a1 transcription via the MTK1/MKK3/6/p38 axis and activation of C/EBPbeta-TAD4 in terminally differentiating chondrocytes. J Biol Chem 2010; 285: 8395-8407.
-
(2010)
J Biol Chem
, vol.285
, pp. 8395-8407
-
-
Tsuchimochi, K.1
Otero, M.2
Dragomir, C.L.3
Plumb, D.A.4
Zerbini, L.F.5
Libermann, T.A.6
-
44
-
-
84938751873
-
MTOR regulates the tumor-promoting senescence-associated secretory phenotype
-
Laberge L, Sun Y, Orjalo AV, Patil CK, Freund A, Liu S et al. mTOR regulates the tumor-promoting senescence-associated secretory phenotype. Nat Cell Biol 2015; 17: 1049-1061.
-
(2015)
Nat Cell Biol
, vol.17
, pp. 1049-1061
-
-
Laberge, L.1
Sun, Y.2
Orjalo, A.V.3
Patil, C.K.4
Freund, A.5
Liu, S.6
-
45
-
-
84873993636
-
Gene expression and epigenetic discovery screen reveal methylation of SFRP2 in prostate cancer
-
Perry AS, OHurley G, Raheem OA, Brennan K, Wong S, OGrady A et al. Gene expression and epigenetic discovery screen reveal methylation of SFRP2 in prostate cancer. Int J Cancer 2013; 132: 1771-1780.
-
(2013)
Int J Cancer
, vol.132
, pp. 1771-1780
-
-
Perry, A.S.1
Ohurley, G.2
Raheem, O.A.3
Brennan, K.4
Wong, S.5
Ogrady, A.6
-
46
-
-
84855916559
-
The role of secreted frizzled-related protein 2 expression in prostate cancer
-
OHurley G, Perry AS, OGrady A, Loftus B, Smyth P, OLeary JJ et al. The role of secreted frizzled-related protein 2 expression in prostate cancer. Histopathology 2011; 59: 1240-1248.
-
(2011)
Histopathology
, vol.59
, pp. 1240-1248
-
-
Ohurley, G.1
Perry, A.S.2
Ogrady, A.3
Loftus, B.4
Smyth, P.5
Oleary, J.J.6
-
47
-
-
84892416698
-
Targeting the tumor microenvironment with interferon-beta bridges innate and adaptive immune responses
-
Yang X, Zhang X, Fu ML, Weichselbaum RR, Gajewski TF, Guo Y et al. Targeting the tumor microenvironment with interferon-beta bridges innate and adaptive immune responses. Cancer Cell 2014; 25: 37-48.
-
(2014)
Cancer Cell
, vol.25
, pp. 37-48
-
-
Yang, X.1
Zhang, X.2
Fu, M.L.3
Weichselbaum, R.R.4
Gajewski, T.F.5
Guo, Y.6
-
48
-
-
84902546715
-
Targeting tumorassociated macrophages with anti-CSF-1R antibody reveals a strategy for cancer therapy
-
Ries CH, Cannarile MA, Hoves S, Benz J, Wartha K, Runza V et al. Targeting tumorassociated macrophages with anti-CSF-1R antibody reveals a strategy for cancer therapy. Cancer Cell 2014; 25: 846-859.
-
(2014)
Cancer Cell
, vol.25
, pp. 846-859
-
-
Ch, R.1
Ma, C.2
Hoves, S.3
Benz, J.4
Wartha, K.5
Runza, V.6
-
49
-
-
84939144106
-
Tumor microenvironment and cancer therapy resistance
-
e-pub ahead of print 10 August
-
Sun Y. Tumor microenvironment and cancer therapy resistance. Cancer Lett 2015; e-pub ahead of print 10 August 2015; doi: 10.1016/j.canlet.2015.07.044.
-
(2015)
Cancer Lett
, vol.2015
-
-
Sun, Y.1
-
50
-
-
34147128086
-
Preoperative hepatic and regional arterial chemotherapy in the prevention of liver metastasis after colorectal cancer surgery
-
Xu J, Zhong Y, Weixin N, Xinyu Q, Yanhan L, Li R et al. Preoperative hepatic and regional arterial chemotherapy in the prevention of liver metastasis after colorectal cancer surgery. Ann Surg 2007; 245: 583-590.
-
(2007)
Ann Surg
, vol.245
, pp. 583-590
-
-
Xu, J.1
Zhong, Y.2
Weixin, N.3
Xinyu, Q.4
Yanhan, L.5
Li, R.6
|